Exact Mass: 151.0746

2-Phenylglycine, also known as a-amino-a-toluate or L-PHG amino acid, belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Outside of the human body, 2-Phenylglycine has been detected, but not quantified in cow milk. This could make 2-phenylglycine a potential biomarker for the consumption of these foods. 2-Phenylglycine is a metabolite described in normal human urine (PMID 14473597) and plasma (PMID 5888801). 2-Phenylglycine is a metabolite described in normal human urine (PMID 14473597) and plasma (PMID 5888801) [HMDB]

Acetaminophen

Bayer select maximum strength headache pain relief formula

The excellent tolerability of therapeutic doses of paracetamol (acetaminophen) is a major factor in the very wide use of the drug. The major problem in the use of paracetamol is its hepatotoxicity after an overdose. Hepatotoxicity has also been reported after therapeutic doses, but critical analysis indicates that most patients with alleged toxicity from therapeutic doses have taken overdoses. Importantly, prospective studies indicate that therapeutic doses of paracetamol are an unlikely cause of hepatotoxicity in patients who ingest moderate to large amounts of alcohol (PMID: 15733027). Single doses of paracetamol are effective analgesics for acute postoperative pain and give rise to few adverse effects (PMID: 14974073). Acetaminophen (AAP) overdose and the resulting hepatotoxicity is an important clinical problem. In addition, AAP is widely used as a prototype hepatotoxin to study mechanisms of chemical-induced cell injury and to test the hepatoprotective potential of new drugs and herbal medicines. Because of its importance, the mechanisms of AAP-induced liver cell injury have been extensively investigated and controversially discussed for many years (PMID: 16863451). The excellent tolerability of therapeutic doses of paracetamol (acetaminophen) is a major factor in the very wide use of the drug. The major problem in the use of paracetamol is its hepatotoxicity after an overdose. Hepatotoxicity has also been reported after therapeutic doses, but critical analysis indicates that most patients with alleged toxicity from therapeutic doses have taken overdoses. Importantly, prospective studies indicate that therapeutic doses of paracetamol are an unlikely cause of hepatotoxicity in patients who ingest moderate to large amounts of alcohol. (PMID 15733027) N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BE - Anilides C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; INTERNAL_ID 1126 D058633 - Antipyretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Phenylpropanolamine

(1S,2R)-2-amino-1-phenylpropan-1-ol

Phenylpropanolamine is a sympathomimetic that acts mainly by causing release of norepinephrine but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. -- Pubchem [HMDB] Phenylpropanolamine is a sympathomimetic that acts mainly by causing release of norepinephrine but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. -- Pubchem. R - Respiratory system > R01 - Nasal preparations > R01B - Nasal decongestants for systemic use > R01BA - Sympathomimetics D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants CONFIDENCE standard compound; INTERNAL_ID 1547

Methyl 2-aminobenzoate

Methyl ester OF O-aminobenzoic acid

Methyl 2-aminobenzoate is found in alcoholic beverages. Methyl 2-aminobenzoate is found in essential oils, including bergamot, orange peel, lemon peel, jasmine, ylang-ylang and neroli. Also present in concord grape, strawberry, star fruit, wines, cocoa, black tea and rice bran. Methyl 2-aminobenzoate is a flavouring agent Found in essential oils, including bergamot, orange peel, lemon peel, jasmine, ylang-ylang and neroliand is also present in concord grape, strawberry, star fruit, wines, cocoa, black tea and rice bran. Flavouring agent.

2-(Methylamino)benzoic acid

N-Methylanthranilic acid, 8ci

2-(Methylamino)benzoic acid is found in citrus. 2-(Methylamino)benzoic acid is isolated from grapefruit peel oi KEIO_ID M127 2-(Methylamino)benzoic acid is the main metabolite of methyl-N-methylanthranilates (MMA) (HY-76705) and is the compound in which the ester group is converted. MMA can be isolated from citrus fruits and has potential analgesic activity. 2-(Methylamino)benzoic acid was used to detect the metabolic levels of MMA in rat liver[1].

N-Methyltyramine

4-Hydroxy-N-methylphenethylamine

N-methyltyramine (NMT) is a phenolic amine. NMT is a potent stimulant of gastrin release present in alcoholic beverages produced by alcoholic fermentation, but not by distillation (i.e.: beer.). NMT is well absorbed in the small intestine, especially in the duodenum and jejunum. NMT is metabolized in the liver (the site of first-pass metabolism), but not in the small-intestinal mucosa. NMT is occasionally present in the stools of children and infants. Satisfactory results have been obtained in treating infective shock with injection of natural Fructus Aurantii immaturus (nat-FAI); the anti-shock effective compositions in FAI have been proved to be synephrine and NMT. (PMID: 10772638, 2570680). Present in germinating barley roots but not dormant grainsand is also present in dormant sawa millet seed hulls, but not hulled seeds. Alkaloid from prosso millet (Panicum miliaceum)

N-(Acetyloxy)benzenamine

Benzenamine, N-(acetyloxy)-

4-Methylamino-benzoic acid

4-(Methylamino)benzoic acid

N-Methylphenylethanolamine

N-Methylphenylethanolamine hydrochloride, (+-)-isomer

N-Methylphenylethanolamine is an intermediate in the metabolism of Tyrosine. It is a substrate for Phenylethanolamine N-methyltransferase. [HMDB] N-Methylphenylethanolamine is an intermediate in the metabolism of Tyrosine. It is a substrate for Phenylethanolamine N-methyltransferase.

4-Hydroxyphenylacetaldoxime

(4-hydroxyphenyl)acetaldehyde oxime

N3-Metyladenine

(R)-Mandelamide

2-Hydroxy-2-phenylacetamide

D000890 - Anti-Infective Agents > D000892 - Anti-Infective Agents, Urinary > D008333 - Mandelic Acids

Mearsine

Gepefrine

alpha-Methyl-m-tyramine

C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

2-Amino-3-methylbenzoate

2-Amino-3-methylbenzoic acid, monopotassium salt

2-Amino-3-methylbenzoate is a metabolite of lidocaine. Lidocaine, Xylocaine, or lignocaine is a common local anesthetic and antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic or as a local anesthetic for minor surgery. (Wikipedia)

Dopamine quinone

Dopaminoquinone;dopamine o-quinone;DoQ;4-(2-aminoethyl)-1,2-benzoquinone;4-(2-aminoethyl)-O-benzoquinone

Dopamine-quinone is synthesized by oxidation of the catechol ring of dopamine. If this occurs within the neuronal cytosol, the quinone may react with cytosolic components, particularly with cysteine residues. (PMID: 12835101). Dopamine quinone is produce by the reaction between dopamine and oxygen, with water as the byproduct. The reaction is catalyzed by the tyrosinase precursor. Dopamine-quinone is synthesized by oxidation of the catechol ring of dopamine. If this occurs within the neuronal cytosol, the quinone may react with cytosolic components, particularly with cysteine residues. (PMID: 12835101)

Leukoaminochrome

2,3-Dihydro-5,6-dihydroxyindole

Leukoaminochrome is formed by cyclization of dopamine o-quinone to dopaminochrome. Oxidation of leukoaminochrome to dopaminochrome and polymerization of dopaminochrome to neuromelanin . The DA oxidation can occur spontaneously, is accelerated by transition metal ions (Mn2+ or Fe2+), or can be catalyzed by a number of different enzymes [HMDB] Leukoaminochrome is formed by cyclization of dopamine o-quinone to dopaminochrome. Oxidation of leukoaminochrome to dopaminochrome and polymerization of dopaminochrome to neuromelanin. The DA oxidation can occur spontaneously, is accelerated by transition metal ions (Mn2+ or Fe2+), or can be catalyzed by a number of different enzymes.

Phenicarbazide

1-Carbamoyl-2-phenylhydrazin

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

1-aci-nitro-2-(phenyl)ethane

N-hydroxy-2-phenylethanimine oxide

(Z)-[(4-hydroxyphenyl)acetaldehyde oxime]

(z)-[(4-hydroxyphenyl)acetaldehyde oxime] is a member of the class of compounds known as 1-hydroxy-2-unsubstituted benzenoids. 1-hydroxy-2-unsubstituted benzenoids are phenols that a unsubstituted at the 2-position (z)-[(4-hydroxyphenyl)acetaldehyde oxime] is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). (z)-[(4-hydroxyphenyl)acetaldehyde oxime] can be found in a number of food items such as sugar apple, chestnut, mandarin orange (clementine, tangerine), and gooseberry, which makes (z)-[(4-hydroxyphenyl)acetaldehyde oxime] a potential biomarker for the consumption of these food products.

phenylpropanolamine

l-Phenylpropanolamine

R - Respiratory system > R01 - Nasal preparations > R01B - Nasal decongestants for systemic use > R01BA - Sympathomimetics D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants

Cathine

Benzenemethanol, alpha-(1-aminoethyl)-, (S-(R*,S*))-

A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products An amphetamine that is propylbenzene substituted by a hydroxy group at position 1 and by an amino group at position 2 (the 1S,2S-stereoisomer). D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants CONFIDENCE standard compound; EAWAG_UCHEM_ID 3335 EAWAG_UCHEM_ID 3335; CONFIDENCE standard compound

DL-Norephedrine

DL-erythro-2-Amino-1-phenyl-1-propanol hydrochloride

2'-Hydroxyacetanilide

N-(2-hydroxyphenyl)ethanimidic acid

2-Hydroxyacetanilide, also known as N-(2-hydroxyphenyl)acetamide (HPAA), belongs to the class of organic compounds known as aminophenols. These are organic compounds containing an amino group attached to a phenol. HPAA is a benzoxazinoid metabolite. It is a potential urinary biomarker of whole grain intake (PMID: 27805021).

4-Hydroxyamphetamine

Hydrobromide, hydroxyamphetamine

4-Hydroxyamphetamine is a metabolite of methamphetamine. Methamphetamine, also known as methamfetamine, meth, N-methylamphetamine, methylamphetamine, and desoxyephedrine, is a psychostimulant of the phenethylamine and amphetamine class of psychoactive drugs. Methamphetamine increases alertness, concentration, energy, and in high doses, can induce euphoria, enhance self-esteem and increase libido. (Wikipedia) D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent

Ethyl nicotinate

Ethyl pyridine-3-carboxylate

Ethyl nicotinate, also known as nicotine acid ethyl ester or mucotherm, is a member of the class of compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group. Ethyl nicotinate is soluble (in water) and a strong basic compound (based on its pKa). Ethyl nicotinate can be found in sweet orange, which makes ethyl nicotinate a potential biomarker for the consumption of this food product. Ethyl nicotinate exists in all eukaryotes, ranging from yeast to humans. Ethyl nicotinate, also known as mucotherm, belongs to the class of organic compounds known as pyridinecarboxylic acids. Pyridinecarboxylic acids are compounds containing a pyridine ring bearing a carboxylic acid group. ethyl nicotinate has been detected, but not quantified, in sweet oranges. This could make ethyl nicotinate a potential biomarker for the consumption of these foods.

3alpha,4,7,7alpha-Tetrahydro-1H-isoindole-1,3(2H)-dione

3-alpha,4,7,7-alpha-Tetrahydro-1H-isoindole-1,3(2H)-dione

Potential food contaminant arising from the metabolism of Captan CXH76-I.

1,2,3,4,5,6-Hexahydro-5-methyl-7H-cyclopenta[b]pyridin-7-one

Proline-derived Maillard product. Proline-derived Maillard product

1,2,3,4,5,6-Hexahydro-6-methyl-7H-cyclopenta[b]pyridin-7-one

Proline-derived Maillard product. Proline-derived Maillard product

2,3,4,5,6,7-Hexahydrocyclopent[b]azepin-8(1H)-one

2,3,4,5,6,7-hexahydro-Cyclopent[b]azepin-8(1H)-one

Proline-specific Maillard product. 2,3,4,5,6,7-Hexahydrocyclopent[b]azepin-8(1H)-one is a flavouring ingredient. Proline-specific Maillard product. Flavouring ingredient

2-(1-Pyrrolidinyl)-2-cyclopenten-1-one

2-(pyrrolidin-1-yl)cyclopent-2-en-1-one

Proline-derived Maillard product. Proline-derived Maillard product

2-(2-Furanyl)piperidine

2-(furan-2-yl)piperidine

Proline-derived Maillard product. Proline-derived Maillard product

1-Furfurylpyrrolidine

1-[(furan-2-yl)methyl]pyrrolidine

1-Furfurylpyrrolidine is found in mollusks. Proline-derived Maillard product. 1-Furfurylpyrrolidine is a constituent of dried, roasted squid aroma. Proline-derived Maillard product. Constituent of dried, roasted squid aroma. 1-Furfurylpyrrolidine is found in mollusks.

2-Acetyl-3-ethylidene-3,4,5,6-tetrahydropyridine

1-[(3Z)-3-ethylidene-3,4,5,6-tetrahydropyridin-2-yl]ethan-1-one

Proline or lysine-derived Maillard product. Proline or lysine-derived Maillard product

2-(5-Methyl-2-furanyl)pyrrolidine

Putative proline-derived Maillard product formed in model reactions with 1-pyrroline and ascorbic acid. Putative proline-derived Maillard product formed in model reactions with 1-pyrroline and ascorbic acid

chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 5a

Chondroitin sulphuric acid e (galnac4,6Dis-glca), precursor 5a

chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 5a is classified as a member of the N-phenylureas. N-phenylureas are compounds containing a N-phenylurea moiety, which is structurally characterized by a phenyl group linked to one nitrogen atom of a urea group. chondroitin sulfate E (GalNAc4,6diS-GlcA), precursor 5a is considered to be slightly soluble (in water) and relatively neutral

(-)-Norephedrine

Hydrochloride, phenylpropanolamine

2-Benzyl-aminoethanol

1-amino-3-phenylpropan-1-ol

2-Ethylnitrobenzene

Metacetamol

N-(3-hydroxyphenyl)ethanimidic acid

D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics

3-Methoxybenzamide

3-Methoxybenzene-1-carboximidate

D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors

3,4,5,6-Tetrahydrophthalimide

2,3,4,5,6,7-hexahydro-1H-isoindole-1,3-dione

4-(Aminomethyl)benzoic acid

Para-aminomethylbenzoic acid

B - Blood and blood forming organs > B02 - Antihemorrhagics > B02A - Antifibrinolytics > B02AA - Amino acids D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics D050299 - Fibrin Modulating Agents > D000933 - Antifibrinolytic Agents D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

4-Aminobenzohydrazide

4-Aminobenzoic acid-hydrazide

4-Aminophenylacetic acid

benzeneacetic acid, 4-amino-

4-Methoxy-N,N-dimethylaniline

4-methoxy-N,N-dimethylaniline

2-((2-Chloroethyl)ethylamino)ethanol

2-[(2-chloroethyl)(ethyl)amino]ethan-1-ol

L-Phenylalaninol

2-amino-3-phenylpropan-1-ol

4-Methyl-1,4-dihydropyridine-3,5-dicarbaldehyde

4-Methyl-1,4-dihydro-3,5-pyridinedicarboxaldehyde

N-Phenylglycine

N-Phenylglycine, potassium salt

2-Amino-1-phenylpropan-2-ol

1-nitro-2-phenylethane

Flavouring compound [Flavornet]

Paracetamol

4-Acetamidophenol

2-Aminophenylaceticacid

2-Aminophenylacetic acid

A member of the class of phenylacetic acids that is phenylacetic acid which carries an amino group at position 2 of the phenyl ring. A fungal metabolite produced by Colletotrichum gloeosporioides.

Oxime-4-Hydroxyphenylacetaldehyde

4-(3-aminopropyl)phenol

2,3-dimethyl-4-nitrosophenol

1-(1H-pyrrol-2-yl)butane-1,2-dione

Methyl 3-(1H-pyrrol-3-yl)prop-2-enoate

4-Methoxy-N-methylbenzylamine

1-Butyl-1H-pyrrole-2-carbaldehyde

2,5-dimethyl-4-nitrosophenol

Methyl 4-aminobenzoate

2-ethyl-2,5-cyclohexadiene-1,4-dione 4-oxime

2,4,6,6-Tetramethyl-3(6H)-pyridinone

(5Z)-1,5-dihydro-4-methyl-5-(2-methylpropylidene)pyrrol-2(2H)-one|(5Z)-4-methyl-5-(2-methylpropylidene)-3-pyrrolin-2-one|(Z)-5-isobutylidene-4-methyl-1,5-dihydropyrrole-2-one|(Z)-pulchellalactam|5-(Z)-isobutylidene-4-methyl-1,5-dihydropyrrol-2-one|pulchellactam|pulchellalactam

(2-(dimethylamino)phenyl)methanol

4-Methoxybenzaldoxime

p-hydroxyphenylacetamide

Streptokordin

A pyridone that is pyridin-2(1H)-one substituted by an acetyl group at position 4 and a methyl group at position 6. It is isolated from the fermentation broth of Streptomyces sp. KORDI-3238 and exhibits moderate cytotoxicity against a number of human cancer cell lines.

4-Methoxyphenethylamine

4-Methoxyphenylethylamine

D-Ribamine

C5H13NO4 (151.0845)

1-[4-(aminomethyl)phenyl]ethan-1-ol

Benzylcarbamic Acid

(2-aminophenyl)urea

Loroquine

3-Methoxybenzamide

D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors

4-Methoxybenzamide

2-Amino-3-hydroxyacetophenone

2-Amino-5-hydroxyacetophenone

ETHYL PICOLINATE

1-(2-Amino-5-hydroxyphenyl)ethanone

Phenylnitroethane

(2-Nitroethyl)benzene

1H-Indole-2,3-diol, 2,3-dihydro-

Norephedrine

2-Amino-1-phenyl-1-propanol

R - Respiratory system > R01 - Nasal preparations > R01B - Nasal decongestants for systemic use > R01BA - Sympathomimetics D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants CONFIDENCE standard compound; EAWAG_UCHEM_ID 3684

Phenylglycine

Annotation level-3 IPB_RECORD: 2761; CONFIDENCE confident structure

Acetaminophen

Acetaminophen / paracetamol

N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BE - Anilides C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D058633 - Antipyretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2697; ORIGINAL_PRECURSOR_SCAN_NO 2695 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2693; ORIGINAL_PRECURSOR_SCAN_NO 2690 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2673; ORIGINAL_PRECURSOR_SCAN_NO 2671 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2686; ORIGINAL_PRECURSOR_SCAN_NO 2684 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2692; ORIGINAL_PRECURSOR_SCAN_NO 2689 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4204; ORIGINAL_PRECURSOR_SCAN_NO 4203 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4211; ORIGINAL_PRECURSOR_SCAN_NO 4209 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4223; ORIGINAL_PRECURSOR_SCAN_NO 4221 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4232; ORIGINAL_PRECURSOR_SCAN_NO 4231 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4241; ORIGINAL_PRECURSOR_SCAN_NO 4238 CONFIDENCE standard compound; INTERNAL_ID 820; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4234; ORIGINAL_PRECURSOR_SCAN_NO 4232 CONFIDENCE standard compound; INTERNAL_ID 2767 MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; RZVAJINKPMORJF-UHFFFAOYSA-N_STSL_0199_Acetaminophen_0125fmol_180831_S2_L02M02_53; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. CONFIDENCE standard compound; INTERNAL_ID 8667 CONFIDENCE standard compound; INTERNAL_ID 8050 CONFIDENCE standard compound; INTERNAL_ID 4091 INTERNAL_ID 4091; CONFIDENCE standard compound

N-Methyltyramine

2-Phenylglycine

(±)-α-Aminophenylacetic acid

N-Methylanthranilic acid

An aromatic amino acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is substituted by a methyl group. 2-(Methylamino)benzoic acid is the main metabolite of methyl-N-methylanthranilates (MMA) (HY-76705) and is the compound in which the ester group is converted. MMA can be isolated from citrus fruits and has potential analgesic activity. 2-(Methylamino)benzoic acid was used to detect the metabolic levels of MMA in rat liver[1].

Acetominophen

2-Hydroxyacetanilide

acetoaminophenol

N-(2-Hydroxyphenyl)acetamide

CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2697; ORIGINAL_PRECURSOR_SCAN_NO 2695 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2693; ORIGINAL_PRECURSOR_SCAN_NO 2690 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2673; ORIGINAL_PRECURSOR_SCAN_NO 2671 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2686; ORIGINAL_PRECURSOR_SCAN_NO 2684 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2692; ORIGINAL_PRECURSOR_SCAN_NO 2689 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4204; ORIGINAL_PRECURSOR_SCAN_NO 4203 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4211; ORIGINAL_PRECURSOR_SCAN_NO 4209 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4223; ORIGINAL_PRECURSOR_SCAN_NO 4221 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4232; ORIGINAL_PRECURSOR_SCAN_NO 4231 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4241; ORIGINAL_PRECURSOR_SCAN_NO 4238 CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4220; ORIGINAL_PRECURSOR_SCAN_NO 4218 DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4220; CONFIDENCE standard compound; INTERNAL_ID 695; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; ORIGINAL_PRECURSOR_SCAN_NO 4218

cis-1,2,3,6-Tetrahydrophthalimide

cis-3a,4,7,7a-Tetrahydro-1H-isoindole-1,3(2H)-dione

CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2697; ORIGINAL_PRECURSOR_SCAN_NO 2695 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2693; ORIGINAL_PRECURSOR_SCAN_NO 2690 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2673; ORIGINAL_PRECURSOR_SCAN_NO 2671 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2686; ORIGINAL_PRECURSOR_SCAN_NO 2684 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2692; ORIGINAL_PRECURSOR_SCAN_NO 2689 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4204; ORIGINAL_PRECURSOR_SCAN_NO 4203 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4211; ORIGINAL_PRECURSOR_SCAN_NO 4209 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4223; ORIGINAL_PRECURSOR_SCAN_NO 4221 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4232; ORIGINAL_PRECURSOR_SCAN_NO 4231 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4241; ORIGINAL_PRECURSOR_SCAN_NO 4238 CONFIDENCE standard compound; INTERNAL_ID 1053; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4234; ORIGINAL_PRECURSOR_SCAN_NO 4232

N-Phenylglycine; AIF; CE0; CorrDec

N-Phenylglycine; AIF; CE10; CorrDec

N-Phenylglycine; AIF; CE30; CorrDec

N-Phenylglycine; AIF; CE0; MS2Dec

N-Phenylglycine; AIF; CE10; MS2Dec

N-Phenylglycine; AIF; CE30; MS2Dec

2-Phenylglycine; CE0; CorrDec

2-Phenylglycine; CE10; CorrDec

2-Phenylglycine; CE30; CorrDec

2-Phenylglycine; CE0; MS2Dec

2-Phenylglycine; CE10; MS2Dec

2-Phenylglycine; CE30; MS2Dec

2-Phenylglycine [M+H-NH2]+; AIF; CE0; CorrDec

2-Phenylglycine [M+H-NH2]+; AIF; CE10; CorrDec

2-Phenylglycine [M+H-NH2]+; AIF; CE30; CorrDec

2-Phenylglycine [M+H-NH2]+; AIF; CE0; MS2Dec

2-Phenylglycine [M+H-NH2]+; AIF; CE10; MS2Dec

2-Phenylglycine [M+H-NH2]+; AIF; CE30; MS2Dec

N-Phenylglycine; LC-tDDA; CE10

N-Phenylglycine; LC-tDDA; CE20

N-Phenylglycine; LC-tDDA; CE30

N-Phenylglycine; LC-tDDA; CE40

2-Phenylglycine; LC-tDDA; CE10

2-Phenylglycine; LC-tDDA; CE20

2-Phenylglycine; LC-tDDA; CE30

2-Phenylglycine; LC-tDDA; CE40

4-Acetamidophenol

(+)-Norephedrine

An amphetamine that is propylbenzene substituted by a hydroxy group at position 1 and by an amino group at position 2 (the 1S,2R-stereoisomer).

2-hydroxyacetanilide_major

(3-Hydroxyphenyl)trimethylammonium

2-Ethylisonicotinic acid

4-Pyridinecarboxylicacid,2-ethyl-(9CI)

A pyridinemonocarboxylic acid that is isonicotinic acid with an ethyl substituent at position 2 on the ring.

PHENYLACETOHYDROXAMIC ACID

Carbomethoxyaniline

Methyl ester OF O-aminobenzoic acid

«

3-alpha,4,7,7-alpha-Tetrahydro-1H-isoindole-1,3(2H)-dione

trans-4-Aminocyclohexanol hydrochloride (1:1)

3-Pyridinecarboxaldehyde, 2-methoxy-6-methyl- (9CI)

2-METHYL-3-[4-METHYL(3,5-OXAZOLYL)]PROP-2-ENAL

6-Hydroxybenzomorpholine

2-(5-Methylisoxazol-3-yl)but-3-yn-2-ol

5-Fluoro-1H-pyrrolo[2,3-b]pyridin-6-amine

4,5,5-Trimethyl-2-oxo-2,5-dihydro-3-furancarbonitrile

1,4-Dimethyl-2-nitrobenzene

formic acid, compound with 2,2-iminobis[ethanol] (1:1)

C5H13NO4 (151.0845)

2,6-Dimethyl-4-nitrosophenol

5-acetyl-2-amino-4-methylpyrimidine

3,4-Dihydro-2H-1,4-benzoxazin-8-ol

3,4-Dihydro-2H-pyrano[3,2-b]pyridin-4-ol

2,6-Dimethylpyridine-3-boronic acid

4-Piperidinemethanol,hydrochloride (1:1)

2,6-Dimethylpyridine-4-carboxylic acid

1-(carboxylatomethyl)methylpyridinium

1,1-Diethylguanidine hydrochloride (1:1)

C5H14ClN3 (151.0876)

3-Isopropoxyazetidine hydrochloride

3-Amino-6-fluoro-1H-indazole

7-fluoro-1,2,3,4-tetrahydroisoquinoline

2-Pyridin-4-ylacetohydrazide

3-hydroxy-N-methylbenzamide

3,4-DIAMINO-BENZAMIDE

phenoxyacetamide

2-Phenoxyacetamide

2-Methoxybenzamide

5-Fluoro-1H-indazol-3-amine

3-Pyridinecarboxylicacid,2-methyl-,hydrazide(9CI)

4-(Trimethylsilyl)pyridine

C8H13NSi (151.0817)

3,3-Dimethylmorpholine hydrochloride (1:1)

4-fluoro-3aH-indazol-3-amine

6-amino-2-cyclopropyl-1H-pyrimidin-4-one

N-cyclohexylhydroxylamine hydrochloride

Methyl 2-methylnicotinate

3-Amino-2-hydroxyacetophenone

3-Aminomethylbenzoicacid

4H-1,3-benzodioxin-6-amine

4,5-DIHYDRO-1,3-BENZODIOXINE-6-AMINE

Benzyl carbamate

Ethyl isonicotinate

Trans-2-Aminocyclohexanol HCl

4-Hydrazinobenzamide

N-(5-AMINOPYRIDIN-2-YL)GUANIDINE

2-aminobenzhydrazide

6-METHYLBENZO[D][1,3]DIOXOL-5-AMINE

2-Amino-4-methylbenzoic acid

8-fluoro-1,2,3,4-tetrahydroquinoline

5-Amino-1,4-benzodioxane

2-Methoxy-5-methylnicotinaldehyde

2-ETHOXYPYRIDINE-3-CARBALDEHYDE

6-fluoro-3-methyl-1H-pyrazolo[3,4-b]pyridine

1,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carbaldehyde

4-Methyl Salicylamide

5-Methylsalicylamide

3-amino-4-methoxybenzaldehyde

Methyl 6-methylpyridine-2-carboxylate

[4-(Aminomethyl)phenyl]boronic acid

N-(6-Aminopyridin-2-yl)acetamid

1-(3-methoxypyridin-2-yl)ethanone

N-Methyl-2-amino-3-nicotinamide

6-(Methoxymethyl)-2-pyridinecarbaldehyde

5-FLUORO-2-METHYLINDOLINE

6-Methoxy-3-methylpicolinaldehyde

2-amino-6-methoxybenzaldehyde

3-(furfuryloxy)propiononitrile

1-(2-Methoxypyridin-3-yl)ethanone

2,6-Dimethylnicotinic acid

3-Amino-4-methylbenzoic acid

1H-Inden-1-amine,6-fluoro-2,3-dihydro-,(-)-(9CI)

Ethyl 2-picolinate

5-formyl-2-methoxy-4-picoline

Methyl 4-methylnicotinate

2-FLUORO-4-HYDRAZINO-BENZONITRILE

4-HYDRAZINOPIPERIDINEHYDROCHLORIDE

C5H14ClN3 (151.0876)

2-(Trimethylsilyl)pyridine

C8H13NSi (151.0817)

5-ACETYL-6-METHYL-2(1H)-PYRIDINONE

4-Amino-2-methylbenzoic acid

4-Nitro-m-xylene

2,5-dimethyl-4-nitroso-phenol

4-methylpyridine-3-carbohydrazide

3-METHYLPIPERIDIN-4-OL

3-propoxyazetidine hydrochloride

1-(4-amino-3-hydroxyphenyl)ethan-1-one

6-Fluoro-1H-indazol-4-amine

azepan-4-ol hydrochloride

(5-Ethylpyridin-3-yl)boronic acid

2-(TETRAHYDROFURAN-3-YL)ETHANAMINE HYDROCHLORIDE

Piperidin-3-ylmethanol hydrochloride

1-(4-Amino-2-hydroxyphenyl)ethanone

1-(3-Fluorophenyl)cyclopropanamine

(3-Amino-4-methylphenyl)boronic acid

2,3-dimethylpyridine-4-carboxylic acid

4-Fluoro-2,3-dihydro-1H-inden-1-amine

1-Amino-3,3-dimethyl-butan-2-oneHCl

(4-AMINO-PHENYL)-(4-METHYL-PIPERIDIN-1-YL)-METHANONE

1,3-Benzodioxol-5-Ylmethylamine

ZR C1 BVQ

6-Fluoro-1,2,3,4-tetrahydroquinoline

1-(4-methoxypyridin-2-yl)ethanone

2,4-dimethyl-3-pyridinecarboxylic acid

4-Pyridinecarboxylicacid, 2-methyl-, hydrazide

Cis-2-aminocyclohexanol hydrochloride

pyridin-3-ylmethyl acetate

3-(Methoxymethyl)pyrrolidine

1-(5-Methoxy-3-pyridinyl)ethanone

1H-Imidazole-4-carboxamide,N-2-propenyl-(9CI)

4-Methyl-4-piperidinol hydrochloride (1:1)

1H-Imidazole-1-carboxamide,N-2-propenyl-(9CI)

N-Cyclopropyl-1-imidazolecarboxamide

Methyl 3-pyridyl acetate

4-Fluoro-1H-indazol-5-amine

(4,5,6,7-2H4)-1H-Isoindole-1,3(2H)-dione

C8HD4NO2 (151.0571)

(6R,7S)-2-ACETYL-2-AZA-BICYCLO[2.2.1]HEPT-5-EN-3-ONE

4-Ethylnitrobenzene

1-Ethyl-4-nitrobenzene

4-AMINOMETHYLTETRAHYDROPYRAN HYDROCHLORIDE

2-DIMETHYLAMINO-PYRIMIDINE-4-CARBALDEHYDE

Ethyl butyrimidate hydrochloride

4,6-dimethylnicotinic acid

5-ETHYLPYRIDINE-2-CARBOXYLIC ACID

2-(Dimethylamino)-5-pyrimidinecarbaldehyde

2-(Isopropylsulfonyl)ethanamine

C5H13NO2S (151.0667)

3-Amino-5-methylbenzoic acid

N,N-diethylmethanesulfonamide

C5H13NO2S (151.0667)

(S)-(+)-Mandelamide

(2S)-2-hydroxy-2-phenylacetamide

2-Amino-4-fluorobenzimidazole

4-METHOXY-5-METHYLPICOLINALDEHYDE

1-(3-Aminophenyl)urea

2-hydroxy-3-methylbenzamide

1,3-Benzodioxole-2-methanamine

(E)-METHYL 3-(1H-PYRROL-3-YL)ACRYLATE

2-Ethylnicotinicacid

Carbamic acid,N-phenyl-,methyl ester

1-(3-Aminophenyl)urea hydrochloride (1:1)

5-Fluoro-2,3-dihydro-1H-inden-2-amine

Nitroxylol

5-Amino-2-methylbenzoic acid

Methyl 4-Pyridinylacetate

N-(4-aminoanilino)formamide

1-Methylbiguanide monohydrochloride

C3H10ClN5 (151.0625)

2-Amino-3-methoxybenzaldehyde

Benzaldehyde,2-amino-4-methoxy-

Morpholinium,4,4-dimethyl-, chloride (1:1)

2,2-dimethylmorpholine hydrochloride

3-Hydroxy-1-isopropylazetidine hydrochloride

2-acetyl-2-azabicyclo[2.2.1]hept-5-en-3-one

α,α,α-TRIFLUOROTOLUENE-D5

C7D5F3 (151.0657)

2-amino-6-methylpyrimidine-4-carboxamidine

4-Fluoro-1H-indazol-7-amine

1,2,3,6-TETRAHYDRO-4-(TRIFLUOROMETHYL)PYRIDINE

C6H8F3N (151.0609)

3-AcetaMido-4-Methylpyridazine

1,4-Benzodioxan-6-amine

6-METHYLNICOTINOYLHYDRAZIDE

1-(6-Methoxy-2-pyridinyl)ethanone

Pyrido[3,4-d]pyrimidin-4(4aH)-one, 5,6,7,8-tetrahydro-

4-acetamido-3-aminopyridine

4-hydroxy-N-methylbenzamide

N-hydroxymethylbenzamide

Carbamic acid,N-methyl-, phenyl ester

2-Methyl-3-aminobenzoic acid

3-(Methylamino)benzoic acid

Methyl 2-pyridinylacetate

O-(CYCLOPENTYLMETHYL)HYDROXYLAMINE HYDROCHLORIDE

3-methylpyridine-2-amidoxime

6-ETHOXYPICOLINALDEHYDE

5,6-Dimethylpicolinic acid

6-Methoxy-2-methylnicotinaldehyde

1,5,6,7-Tetrahydro-4-hydroxy-2H-cyclopenta[b]pyridin-2-one

5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one

2,3-Diaminobenzamide

tetrahydropyran-2-ylmethylamine hydrochloride

(R)-2-(HYDROXYMETHYL)PIPERIDINE HYDROCHLORIDE

1H-Indazol-5-amine,3-fluoro-(9CI)

Pyrrole-2,4-dicarboxaldehyde, 3,5-dimethyl- (6CI,7CI,8CI)

3,6-dimethylpyridine-2-carboxylic acid

BENZALDEHYDE,4-AMINO-3-METHOXY-(9CL)

(3R)-3-Ethylmorpholine hydrochloride (1:1)

(S)-2-(HYDROXYMETHYL)PIPERIDINE HYDROCHLORIDE

2-Hydroxy-6-methylbenzamide

5-Acetyl-2-methoxypyridine

(6-Methyl-3-pyridinyl)acetic acid

1-(2-Fluorophenyl)cyclopropanamine

4-Fluoro-1H-pyrrolo[2,3-b]pyridin-5-amine

Methyl 3-methyl-4-pyridinecarboxylate

Methyl 5-methylpicolinate

FMOC-L-2-METHYLPHENYLALANINE

4-Ethylpyridine-2-carboxylic acid

3,5-DIMETHYLPICOLINIC ACID

6-Ethylpicolinic acid

3,5-dimethylpyridine-4-carboxylic acid

4-AMINO-N-METHYLNICOTINAMIDE

Methyl 3-methylpyridine-2-carboxylate

2-methoxy-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine

3-Pyridinecarboxylicacid,5-ethyl-(9CI)

4-Fluoro-1H-indazol-3-amine

1-(2-HYDROXYPHENYL)ETHAN-1-ONE OXIME

2-(ethylamino)pyrimidine-5-carbaldehyde

4-Hydroxyacetophenone oxime

1-(Aminomethyl)cyclopentanol hydrochloride

1-(5-Amino-2-hydroxyphenyl)ethanone

5-Fluoro-1H-pyrrolo[2,3-b]pyridin-4-amine

Isoquinoline,5-fluoro-1,2,3,4-tetrahydro-

1-PENTANESULFONAMIDE

C5H13NO2S (151.0667)

1-(4-Methoxy-3-pyridinyl)ethanone

1H-Azepine-1-carboxylicacid,methylester(8CI,9CI)

2-Methyl-tetrahydro-2H-pyran-4-amine HCL

3-Ethylisonicotinic acid

N-(4-hydroxyphenyl)acetamide

Methyl 6-methylnicotinate

2-Acetamido-5-aminopyridine

Pyrazinecarboxaldehyde, 5-(dimethylamino)- (9CI)

7-Fluoro-1H-indazol-3-amine

3-Pyridin-4-yl-propionic acid

5-FLUORO-1H-BENZIMIDAZOLE-2-AMINE

1-Methyl-4-piperidinol hydrochloride

Methyl 5-methylnicotinate

2-Pyridinecarboxaldehydecyclic 1,2-ethanediyl acetal ;;

(NE)-N-[2-(6-aminopyridin-2-yl)ethylidene]hydroxylamine

D-2-Phenylglycine

D-(-)-alpha-Phenylglycine

6-Ethylpyridine-3-boronic acid

2-METHYL-6,7-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-5(4H)-ONE

4-Methyl-5,6-dihydrofuro[2,3-d]pyrimidin-2-amine

2-(4-methylpyridin-2-yl)acetic acid

TRANS-3-AMINO-CYCLOHEXANOL HYDROCHLORIDE

(1R,3S)-3-aminocyclohexan-1-ol,hydrochloride

6-Fluoro-1,2,3,4-tetrahydro-isoquinoline

Pyrrolo[2,3-b]pyrrole-1,2,3(6H)-triamine

(1R,2S)-2-Aminocyclohexanol hydrochloride

8-Fluoro-1,2,3,4-tetrahydroisoquinoline

2,5-dimethylpyridine-4-carboxylic acid

N-METHYLTETRAHYDRO-2H-PYRAN-4-AMINE HYDROCHLORIDE

4-Methyltetrahydro-2H-pyran-4-amine hydrochloride

1H-Azepine-4-carboxylicacid,methylester(9CI)

5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(4aH)-one hydrochloride

4-Amino-3-methylbenzoic acid

2-Amino-4-hydroxyacetophenone

(3R,4R)-(-)-3,4-DIAZIDO-1-(PHENYLMETHYL)PYRROLIDINE

C6H11F2NO (151.0809)

Formamide,N-(4-methoxyphenyl)-

4-Methoxypiperidine hydrochloride (1:1)

[2-(Aminomethyl)phenyl]boronic acid

3-methoxybenzaldoxime

2-Pyridylmethyl acetate

2-Pyridinemethanol,2-acetate

Benzaldehyde,4-methoxy-, oxime

1H-Inden-1-amine,6-fluoro-2,3-dihydro-,(1R)-(9CI)

5-(AMINOMETHYL)NICOTINAMIDE

3-Pyridinecarboxaldehyde, 6-methoxy-5-methyl- (9CI)

dimethoxy(pyridin-3-yl)borane

1H-Inden-1-amine,6-fluoro-2,3-dihydro-(9CI)

6-Fluoro-1H-indazol-5-amine

UNII:283XH39M8X

3,4-Dimethylnitrobenzene

4-ISOCYANATO-1,3,5-TRIMETHYL-1H-PYRAZOLE

(2,6-dimethylpyridin-4-yl)boronic acid

1-Cyclopentene-1-carboxylicacid,5-cyano-,methylester(9CI)

3-pyridin-2-yl-propanoic acid

cis-4-Aminocyclohexanol hydrochloride

2-Amino-5-methylbenzoic acid

1-(4-Fluorophenyl)cyclopropanamine

7-Fluoro-1,2,3,4-tetrahydroquinoline

1-amino-4-methylpiperazine dihydrochloride

C5H14ClN3 (151.0876)

2-amino-6-cyclopropylpyrimidin-4-ol

[4-(Methylamino)phenyl]boronic acid

Paracetamol

A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.

N-(2-Hydroxyethyl)(cyclopropylmethyl)amine Hydrochloride

nitro m-xylene

2,5-DIMETHYLPYRIDIN-3-YLBORONIC ACID

2-Aminomethylbenzoic acid

2,4-DIMETHYLPYRIDINE-3-BORONIC ACID

Methyl 2-methylisonicotinate

4,6-Dimethyl-2-pyridinecarboxylic acid

3-Pyridinecarboxylicacid,2,5-dimethyl-(9CI)

5-Deoxypyridoxal

3-Hydroxy-2,5-dimethylisonicotinaldehyde

3-Methylpiperidin-4-ol hydrochloride

(R)-Piperidin-3-Ylmethanol Hydrochloride

(S)-Piperidin-3-ylmethanol hydrochloride

4-(hydroxymethyl)benzamide

N,N-bis-(2-Cyanoethyl)formamide

2-AMINO-6-IODOPURINE

3-Pyridinepropionic acid

4-Amino-N-hydroxybenzenecarboximidamide

3-Amino-N-hydroxybenzenecarboximidamide

2-methyl-6,7-dihydro-5H-1,3-benzoxazol-4-one

1-(3-PYRIDYLMETHYL)UREA

Methyl 4-methyl-2-pyridinecarboxylate

Ethanone, 1-(2-methoxy-4-pyridinyl)- (9CI)

3-Aminophenylacetic acid

3-fluorobenzyl azide

1-(azidomethyl)-4-fluorobenzene(SALTDATA: FREE)

3-Nitro-2-xylene

trans-2-Amino-cyclohexanol

2,6-dimethylbenzoquinone 4-oxime

1-ethyl-3-nitrobenzene

3-cyclopropyl-4-fluorobenzenamine

o-Anisaldehyde Oxime

5-FLUORO-2,3-DIHYDRO-1H-INDEN-1-AMINE

2-(Aminomethyl)tetrahydropyran

2-Amino-N-hydroxybenzenecarboximidamide

(E)-5-Methyl-2-styrylbenzoxazole

4-Phenylsemicarbazide

Hydrazinecarboxamide,N-phenyl-

3-AMINOBENZHYDRAZIDE

6-ethoxypyridine-3-carbaldehyde

3-amino-2,4-diazabicyclo[4.3.0]nona-3,10-dien-5-one

Pyridine-2-boronic acid dimethyl ester

2-Pyridineacetic acid,hydrazide

1-(3-amino-4-hydroxyphenyl)ethanone

(1S,2R)-2-AMINOCYCLOHEXANOLHYDROCHLORIDE

2-(6-methylpyridin-3-yl)acetic acid

1-[6-(hydroxymethyl)pyridin-2-yl]ethanone

(4-Aminophenyl)acetic acid

8-Hydroxyquinolinolato-lithium

C9H6LiNO (151.0609)

3-AcetaMido-5-Methylpyridazine

1-(5-methoxypyridin-2-yl)ethanone

N-(4-Aminopyridin-2-yl)acetamide

(S)-3-ETHYLMORPHOLINE HYDROCHLORIDE

(5-Methyl-2-pyridinyl)acetic acid

1-cyclopropyl-2-methoxyethanamine hydrochloride

3,4-DIHYDRO-2H-1,4-BENZOXAZIN-7-OL

1H-Benzotriazole,1-(fluoromethyl)-(9CI)

Pyridin-4-ylmethyl acetate

3-Acetoxy-4-methylpyridine

Ethyl nicotinate

4-(Aminomethyl)benzoic acid

Rystal

InChI=1\C8H9NO2\c1-6(10)9-7-3-2-4-8(11)5-7\h2-5,11H,1H3,(H,9,10

LS-775

InChI=1\C8H9NO2\c1-11-8(10)6-4-2-3-5-7(6)9\h2-5H,9H2,1H

AI3-05924

4-14-00-01015 (Beilstein Handbook Reference)

2-(Methylamino)benzoic acid is the main metabolite of methyl-N-methylanthranilates (MMA) (HY-76705) and is the compound in which the ester group is converted. MMA can be isolated from citrus fruits and has potential analgesic activity. 2-(Methylamino)benzoic acid was used to detect the metabolic levels of MMA in rat liver[1].

cis-Indole-2,3-dihydrodiol

(2R)-azaniumyl(phenyl)acetate

1-Aci-nitro-2-phenylethane

(2S)-2-azaniumyl-2-phenyl-ethanoate

N(tele)-methyl-trans-urocanate

C7H7N2O2- (151.0508)

4-Methyladenine

METHYL ANTHRANILATE

Methyl 2-aminobenzoate

A benzoate ester that is the methyl ester of anthranilic acid.

H-Phg-OH

2-Aminophenylacetic acid

5,6-Indolinediol

Dopaminoquinone

Dopamine quinone

A member of the class of 1,2-benzoquinones that is 1,2-benzoquinone in which a hydrogen at para to one of the oxo groups has been replaced by a 2-aminoethyl group.

(Z)-(4-hydroxyphenyl)acetaldehyde oxime

2-Amino-3-methylbenzoate

2-Amino-3-methylbenzoic acid

Metacetamol

1-(3-Hydroxyphenyl)urea

N-Phenylglycine

2-((2-Chloroethyl)ethylamino)ethanol

4-Methyl-1,4-dihydropyridine-3,5-dicarbaldehyde

(+/-)-Mandelamide

2-Hydroxy-2-phenylacetamide

D000890 - Anti-Infective Agents > D000892 - Anti-Infective Agents, Urinary > D008333 - Mandelic Acids

L-alpha-phenylglycine

The S stereoisomer of alpha-phenylglycine.

D-alpha-phenylglycine zwitterion

A D-alpha-amino acid zwitterion arising from transfer of a proton from the carboxy to the amino group of D-alpha-phenylglycine; major species at pH 7.3.

2-Acetamidophenol

A member of the class of phenols that is 2-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group. A positional isomer of paracetamol which possesses anti-inflammatory, anti-arthritic and anti-platelet aggregation properties.

D-alpha-phenylglycine

The R stereoisomer of alpha-phenylglycine.

alpha-phenylglycine

An amino acid with a structure in which a phenyl ring is bonded to the alpha-carbon of glycine.

Leukoaminochrome

A member of the class of indoles that is indoline with hydroxy substituents at positions 5 and 6.

L-alpha-phenylglycine zwitterion

An L-alpha-amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of L-alpha-phenylglycine; major species at pH 7.3.

2-Ethylisonicotinicacid

Ethylisonicotinicacid

Methylaminobenzoic acid

1-(2-hydroxy-6-methylpyridin-4-yl)ethanone

4-methoxy-benzaldehyde oxime